leisure time -WSS

leisure time

author：focus 2025-10-01 10:59:20 - browse：594

David Liu and Jonathan Wosen on the STAT Summit stage. — David Liu (left) with reporter Jonathan Wosen at the 2022 STAT Summit. STAT

David Liu, the Broad Institute biochemist behind two powerful forms of genome editing, is launching a company focused on delivering gene-editing machinery to precise cells and tissues in the body, STAT has learned.

The company, known as Nvelop, already raised a $100 million seed round last year, according to PitchBook. It is being run by Jeff Walsh, a former top executive at Bluebird Bio, and it recently recruited Bluebird’s head of research, Melissa Bonner, according to two people with knowledge of the situation. Bluebird had not previously disclosed Bonner’s departure.

Nvelop is the latest entry in a race among top labs and deep-pocketed investors to solve a delivery problem that has stunted efforts to turn CRISPR and other genetic tools into disease-altering medicines. The goal is to develop a cargo system precise enough to deliver CRISPR or other machinery to cells of a researchers’ choosing, particularly tissues that have been hard to reach with previous approaches, like neurons, muscle, and blood stem cells.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Will.i.am, Britney Spears release new single, 'Mind Your Business'

WSS

Quicker fix for pulse oximeters urged during FDA public meeting

New rules on organ donation and transplantation 'will bring chaos'

FDA drug safety: Singulair case shows systemic surveillance flaws

Providers still hesitate to prescribe buprenorphine, study finds

Will.i.am, Britney Spears release new single, 'Mind Your Business'

Commercial surrogacy can be ethical, despite pope’s claims

leisure time

leisure time

hotspot

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

New rules on organ donation and transplantation 'will bring chaos'

Dobbs anniversary: the lost opportunity of abortion as health care

Biden administration opens offers in Medicare drug price negotiations

Alkermes shareholders re

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

BioMarin wins approval for gene therapy to treat hemophilia A

Why an extreme heat and wildfire smoke combination can be so dangerous

At least 13 dead in Texas as scorching temps continue

The real point of Kenneth Smith’s execution by nitrogen gas

entertainment

Do digital therapeutics have a future in medicine?

Artificial intelligence advances fuel industry trying to preserve loved ones after death

Cognito secures funding to test medical device for Alzheimer's

SAMSHA loosens regulations on methadone treatment centers

Body of missing toddler recovered in Delaware River days after flood: Police

Marvel Studios reveals new trailer for 'The Marvels': Watch here

focus

explore

focus

leisure time